BeStock  
Stocks › Biotechnology › NTLA

Intellia Therapeutics NTLA

US equityMarket cap rank #2922BiotechnologyGene Editing
$10.00 +$0.48 (+5.04%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $10.00 +0.01%
Open$9.34
Prev close$9.52
Day range$9.30 – $10.40
Volume15.19M
Market cap$1.40B
P/E (TTM)–
Dividend yield–

Analyst view

ConsensusHold
Analysts11
Average target$19.20+92.0% vs. price
  • Buy 36%
  • Hold 45%
  • Sell 18%
Low $8.00Now $10.00Avg $19.20High $49.00

Recent rating changes

The last 20 actions on file set price targets from $8.00 to $49.00, averaging $19.21.

DateFirmRatingTarget
13 Nov 2026 BofA Securities HOLD $16.00
13 Nov 2026 H.C. Wainwright BUY $25.00
9 Nov 2026 CCORF BUY $49.00
9 Nov 2026 J.P. Morgan SELL $9.00
6 Nov 2026 JonesTrading BUY $27.00
6 Nov 2026 BofA Securities HOLD $16.00
6 Nov 2026 Wedbush HOLD $13.00
6 Nov 2026 Morgan Stanley HOLD $15.00
6 Nov 2026 H.C. Wainwright BUY $25.00
5 Nov 2026 H.C. Wainwright BUY $25.00
5 Nov 2026 RBC Capital HOLD $15.00
15 Oct 2026 Wells Fargo HOLD $15.00
7 Oct 2026 Barclays SELL $8.00
6 Oct 2026 Barclays SELL $8.00
9 Sep 2026 Wedbush HOLD $13.00
9 Sep 2026 H.C. Wainwright BUY $25.00
4 Sep 2026 TD Cowen BUY –
14 Aug 2026 JonesTrading BUY $29.00
10 Aug 2026 Morgan Stanley HOLD $15.00
7 Aug 2026 BofA Securities HOLD $17.00

Discussion

No comments yet — be the first to weigh in on NTLA.

Sign in to join the discussion.

Scroll to Top